CRISPR/Cas9 genome editing is used to insert a codon improved cre recombinase (iCre), a woodchuck hepatitis virus post-transcriptional regulatory element (WPRE; to enhance the mRNA transcript stability), and a polyadenylation sequence in place of the start codon of the tectorin alpha (Tecta) gene.